A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Clinical trial NCT02922543 · COMPLETED
Trial details
- NCT number
- NCT02922543
- Sponsor
- Celgene
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-02-18
- Primary completion
- 2014-10-11
- Enrollment
- 361
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.